Testing effectiveness (Phase 2)Study completedNCT01751152
What this trial is testing
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease
Who this might be right for
InflammationCrohn's Disease
Novo Nordisk A/S 53